Certified by Founder
Lodge
Fore Biotherapeutics
start up
United States
- Philadelphia, PA
- 25/08/2023
- Series D
- $75,000,000
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics. Deeply rooted in science and innovation, our vision is to compassionately contribute to solving cancer.
- Industry Biotechnology
- Website https://fore.bio/
- LinkedIn https://www.linkedin.com/company/forebiotherapeutics/about/
Feltsense | $5,100,000 | (Feb 5, 2026)
Stratus Medical | $10,000,000 | (Feb 5, 2026)
beHuman Corp. | $4,000,000 | (Feb 5, 2026)
Boomband | $4,000,000 | (Feb 5, 2026)
Bedrock Robotics | $270,000,000 | (Feb 5, 2026)
Fibr AI | $7,500,000 | (Feb 5, 2026)
Expert Intelligence™ | $4,700,000 | (Feb 5, 2026)
Positron AI | $230,000,000 | (Feb 5, 2026)
Chamber(US) | $60,000,000 | (Feb 5, 2026)
SENAI | $6,200,000 | (Feb 5, 2026)
OneDome | $25,000,000 | (Feb 4, 2026)
Naoma AI | $440,000 | (Feb 4, 2026)